Deeper Insight in Metastatic Cancer Progression; Epithelial-to- Mesenchymal Transition and Genomic Instability: Implications on Treatment Resistance
- PMID: 33530906
- DOI: 10.2174/1566524021666210202114844
Deeper Insight in Metastatic Cancer Progression; Epithelial-to- Mesenchymal Transition and Genomic Instability: Implications on Treatment Resistance
Abstract
Therapy resistance remains the major obstacle to successful cancer treatment. Epithelial-to- mesenchymal transition [EMT], a cellular reprogramming process involved in embryogenesis and organ development and regulated by a number of transcriptional factors [EMT-TFs] such as ZEB1/2, is recognized for its role in tumor progression and metastasis. Recently, a growing body of evidence has implicated EMT in cancer therapy resistance, but the actual mechanism that underlies this finding has remained elusive. For example, whether it is, the EMT states in itself or the EMT-TFs that modulate chemo or radio-resistance in cancer is still contentious. Here, we summarise the molecular mechanisms of the EMT program and chemotherapeutic resistance in cancer with specific reference to DNA damage response [DDR]. We provide an insight into the molecular interactions that exist between EMT program and DNA repair machinery in cancer and how this interaction influences therapeutic response. We review conflicting studies linking EMT and drug resistance via the DNA damage repair axis. We draw scientific evidence demonstrating how several molecular signalling, including EMT-TFs, work in operational harmony to induce EMT and confer stemness properties on the EMT-susceptible cells. We highlight the role of enhanced DNA damage repair system associated with EMT-derived stem cell-like states in promoting therapy resistance and suggest a multi-targeting modality in combating cancer treatment resistance.
Keywords: Cancer; DNA damage repair; EMT; molecule interaction.; stemness; treatment resistance.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.J Mol Med (Berl). 2016 Jun;94(6):629-44. doi: 10.1007/s00109-016-1420-5. Epub 2016 Apr 20. J Mol Med (Berl). 2016. PMID: 27094812 Review.
-
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.Theranostics. 2018 Mar 8;8(8):2202-2216. doi: 10.7150/thno.24003. eCollection 2018. Theranostics. 2018. PMID: 29721073 Free PMC article.
-
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019. Theranostics. 2019. Retraction in: Theranostics. 2020 Jul 25;10(21):9619. doi: 10.7150/thno.50254. PMID: 31037155 Free PMC article. Retracted.
-
Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.Cell Biol Int. 2018 Mar;42(3):294-302. doi: 10.1002/cbin.10894. Epub 2017 Nov 15. Cell Biol Int. 2018. PMID: 29052277
-
The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis.Int J Mol Sci. 2021 Mar 30;22(7):3591. doi: 10.3390/ijms22073591. Int J Mol Sci. 2021. PMID: 33808323 Free PMC article. Review.
Cited by
-
Dynamic EMT: a multi-tool for tumor progression.EMBO J. 2021 Sep 15;40(18):e108647. doi: 10.15252/embj.2021108647. Epub 2021 Aug 30. EMBO J. 2021. PMID: 34459003 Free PMC article. Review.
-
Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.Int J Mol Sci. 2021 Dec 21;23(1):51. doi: 10.3390/ijms23010051. Int J Mol Sci. 2021. PMID: 35008475 Free PMC article.
-
Prognostic signature detects homologous recombination deficient in glioblastoma.Transl Cancer Res. 2024 Nov 30;13(11):5883-5897. doi: 10.21037/tcr-23-2077. Epub 2024 Nov 21. Transl Cancer Res. 2024. PMID: 39697739 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials